What are INDmoney investors doing with Genomic Valley Biotech shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
-27%
Searches for Genomic Valley Biotech on INDmoney have decreased by 27% over the last 30 days.
Genomic Valley Biotech Stock Performance
as on October 30, 2026 at 9:31 pm IST
Day's Low
₹48.00₹48.10
0.21%
Downside
52 Week's Low
₹20.10₹48.10
58.21%
Downside
Genomic Valley Biotech share price movements today
- Previous Close
- ₹45.81
- Open
- ₹48.10
- Volume
- 9,359.00
- Upper Circuit
- ₹48.10
- Lower Circuit
- ₹43.52
- Day's Low - High
- ₹48.00 - ₹48.10
- 52 Week Low - High
- ₹20.10 - ₹48.10
Genomic Valley Biotech Historical Returns
- 1 Month Return
- + 58.62 %
- 3 Month Return
- + 66.28 %
- 1 Year Return
- + 50.69 %
- 3 Year Return
- + 100.92 %
- 5 Year Return
- + 103.6 %
Genomic Valley Biotech Fundamentals
as on October 30, 2026 at 4:01 pm IST
Market Cap
₹14.69 Cr
Return on Equity (ROE)
9.69
PE Ratio (TTM)
-4581
Return on capital employed (ROCE)
12.11
Industry PE ratio
51.36
Beta (LTM)
0.32
P/B Ratio
4.59
Dividend Yield
0PEG Ratio
13473.53
Quarterly Earnings Growth YOY
-2
EPS (TTM)
0Book Value
0Genomic Valley Biotech Stock Valuation
as on October 30, 2026 at 4:01 pm IST
Genomic Valley Biotech in the last 5 years
Lowest (-4581.00x)
October 29, 2026
Today (-4581.00x)
October 29, 2026
Industry (51.36x)
October 29, 2026
Highest (679.78x)
June 28, 2024
Today’s Price to Earnings Ratio: -4581.00x
Genomic Valley Biotech Technical Analysis
Track how Genomic Valley Biotech technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0 | |
CCI (20) | 35.09 | Neutral |
RSI (14) | 98.84 | |
Momentum (10) | 0 | Neutral |
ADI (14) | 98.96 | Neutral |
Ultimate Oscillator (7,14,28) | 42.86 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 48.1 | Neutral |
EMA (20) | 48.1 | Neutral |
VWMA (20) | 48.1 | Neutral |
SMA (50) | 48.1 | Neutral |
EMA (50) | 48.1 | Bullish |
SMA (200) | 48.07 | Bullish |
EMA (200) | 47.98 | Bullish |
KAMA (200) | 48.1 | Neutral |
DEMA (200) | 48.33 |
Genomic Valley Biotech Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Genomic Valley Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 14.69 | 20.72% | 0.00 | -1 | 2 | |
| NA | 8.86 | -8.6% | 0.67 | -2 | 2 | |
| BUY | 601.92 | -15.51% | 0.53 | 57 | 808 | |
| NA | 14.48 | 15.49% | 0.50 | -2 | 1 | |
| NA | 4.50 | -5.14% | 0.00 | NA | NA |
Genomic Valley Biotech Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Genomic Valley Biotech Ltd Annual Profit & Loss
Figures in Rupees Crores
Genomic Valley Biotech Ltd Cash Flow
Figures in Rupees Crores
Genomic Valley Biotech Corporate Actions
View detailed summary of the earnings and dividend history of Genomic Valley Biotech.
Genomic Valley Biotech Ltd Earnings Results
Genomic Valley Biotech Ltd’s net profit fell -50% since last year same period to ₹0.01Cr in the Q1 2026-2027. On a quarterly growth basis, Genomic Valley Biotech Ltd has generated 200% jump in its net profits since last 3-months.
Read More
Insights on Genomic Valley Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise

In the last 1 month, Genomic Valley stock has moved up by 58.6%
POSITIVE IMPACTBest in 3 Years

In the last 3 years, Genomic Valley has outperformed top 5 stocks with highest market-cap in Fishing & Farming
POSITIVE IMPACTBest in 1 Year

In the last 1 year, Genomic Valley has outperformed top 5 stocks with highest market-cap in Fishing & Farming
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 46.06% of holdings in Sep 2026 quarter
NO EFFECTRetail Holding Unchanged

Retail Investor holdings remained unchanged at 53.94% of holdings in Sep 2026 quarter
About Genomic Valley Biotech Ltd
Revenue: ₹0.00Cr as on September 2026 (Q2 FY27)
Net Profit: ₹0.02Cr as on September 2026 (Q2 FY27)
Chairperson Name: Yogesh Agrawal
| Organisation | Genomic Valley Biotech Ltd |
| Headquarters | New Delhi |
| Industry | Miscellaneous |
| CEO | Yogesh Agrawal |
| E-voting on shares | Click here to vote |
FAQs
What is Genomic Valley Biotech share price today?
Genomic Valley Biotech share price today stands at ₹48.1 as on at the close of the market. Genomic Valley Biotech share today touched a day high of ₹48.1 and a low of ₹48.
What is the 52 week high and 52 week low range for Genomic Valley Biotech share?
Genomic Valley Biotech touched a 52 week high of ₹48.1 and a 52 week low of ₹20.1. Genomic Valley Biotech share price today i.e. is closed at ₹48.1, which is -0.00% down from its 52 week high and 139.30% up from its 52 week low.
What is Genomic Valley Biotech's market capitalisation today?
Genomic Valley Biotech market capitalisation is ₹14.69 Cr as on .
How to buy Genomic Valley Biotech shares?
To buy Genomic Valley Biotech shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 539206 or Genomic Valley Biotech Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Genomic Valley Biotech shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Genomic Valley Biotech trading volume today?
Genomic Valley Biotech trading volume is 9,359.00 as on . This means that 9,359.00 shares of Genomic Valley Biotech were bought and sold on the stock market during today's trading session.